Response by Mahmoud et al to Letter Regarding Article, 'Long-Term Efficacy and Safety of Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Metallic Stents: A Meta-Analysis of Randomized Trials'
| Autor: | Ahmed N. Mahmoud, Amr F. Barakat, Amgad Mentias, Erik Schneibel, Akram Y. Elgendy, Islam Y. Elgendy, Ahmed Abuzaid |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
medicine.medical_specialty
Scaffold Everolimus business.industry medicine.medical_treatment Stent Drug-Eluting Stents 030204 cardiovascular system & hematology law.invention Surgery 03 medical and health sciences 0302 clinical medicine Randomized controlled trial law Meta-analysis Absorbable Implants Medicine Stents 030212 general & internal medicine Cardiology and Cardiovascular Medicine business Randomized Controlled Trials as Topic medicine.drug Bioresorbable vascular scaffold |
| Zdroj: | Circulation: Cardiovascular Interventions. 10 |
| ISSN: | 1941-7632 1941-7640 |
| DOI: | 10.1161/circinterventions.117.005673 |
| Popis: | We would like to thank Dr Kounis and colleagues for the valuable comments and their interest in our work.1 Kounis et al highlighted a pathophysiological mechanism that might help to explain the higher incidence of definite/probable stent/scaffold thrombosis and very late stent/scaffold thrombosis associated with bioresorbable vascular scaffolds and seen in our meta-analysis. Indeed, our meta-analysis predominately assessed the ABSORB bioresorbable vascular scaffold stent, which is composed of synthetic aliphatic polyesters, that is, poly l-lactide and poly- … |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|